Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
- DOI
- 10.1016/j.jaccao.2022.07.007
- Published
- 2022 Nov
- Container
- JACC. CardioOncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaccao.2022.07.007,
title = {Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.},
author = {Gonzalez-Lopez E and Escobar-Lopez L and Obici L and Saturi G and Bezard M and Saith SE and AbouEzzeddine OF and Mussinelli R and Gagliardi C and Kharoubi M and Griffin JM and Dispenzieri A and Vilches S and Perlini S and Longhi S and Oghina S and Rivas A and Grogan M and Maurer MS and Damy T and Palladini G and Rapezzi C and Garcia-Pavia P},
year = {2022},
journal = {JACC. CardioOncology},
doi = {10.1016/j.jaccao.2022.07.007},
url = {https://doi.org/10.1016/j.jaccao.2022.07.007}
}RIS
TY - JOUR TI - Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. AU - Gonzalez-Lopez E AU - Escobar-Lopez L AU - Obici L AU - Saturi G AU - Bezard M AU - Saith SE AU - AbouEzzeddine OF AU - Mussinelli R AU - Gagliardi C AU - Kharoubi M AU - Griffin JM AU - Dispenzieri A AU - Vilches S AU - Perlini S AU - Longhi S AU - Oghina S AU - Rivas A AU - Grogan M AU - Maurer MS AU - Damy T AU - Palladini G AU - Rapezzi C AU - Garcia-Pavia P PY - 2022 JO - JACC. CardioOncology DO - 10.1016/j.jaccao.2022.07.007 UR - https://doi.org/10.1016/j.jaccao.2022.07.007 ER -
APA
E, G., L, E., L, O., G, S., M, B., SE, S., OF, A., R, M., C, G., M, K., JM, G., A, D., S, V., S, P., S, L., S, O., A, R., M, G., MS, M., T, D., G, P., C, R., & P, G. (2022). Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.. JACC. CardioOncology. https://doi.org/10.1016/j.jaccao.2022.07.007
Source records
- pubmed · retrieved 2026-09-26T04:23:14.971Z